Search results

• Essentium Partnered with Croda Smart Materials

  We are extremely proud to announce an innovative partnership with Essentium and Croda Smart Materials.

• CrodaTherm helps COVID 19 ICU nurses in the United States

  Croda donates cooling vests to Christiana Care Hospital in Newark, Delaware

• Croda officially opens its Crop Care Product Validation Centre

  The new facility is dedicated to serving the agrochemical market and captures our entire research and development cycle.

• Croda develops young minds of tomorrow during COP26

  We have launched new sustainability focused materials for children in STEM

• Delivering the foundation for Croda's R&D digital program

  Global Research and Development Digital Program across all R&D locations.

• Driving innovation in the Agriculture market

  Through Croda’s acquisition of the Incotec Seed Enhancement business in 2015 and the Plant Impact Biostimulants business in 2018, we are well placed to address some of the challenges in the adoption of biologics.

• CroBioticTM 100

  Surveys indicate that malodour of garments is one of the biggest reasons that consumers choose to wash them.

• Customer award for carbon reduction

  We’ve been working in partnership with Syngenta to deliver innovative and sustainable ingredients in a way that meets their commercial and sustainability goals.

• Sustainability without compromise ChromaPur

  Small, manufactured plastic particles, known as microbeads, are used in a wide range of cosmetic and personal care products, with research suggesting that 87% of products from the ten best-selling cosmetics brands contain these microplastics.

• Leveraging Group-wide capabilities to accelerate the development of natural active ingredients

  The move in cosmetics towards replacing synthetic ingredients with sustainable alternatives is increasing demand for naturally sourced actives.

• Biodegradable fragrance encapsulation

  Fragrance encapsulation involves advanced delivery systems that allow the timed release of fragrances, critical in various applications such as laundry, fabric softeners and deodorants.

• Croda supports Pfizer-BioNTech COVID-19 vaccine

  Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs.

• Investing in organic expansion in Agriculture

  Atlox 4913TM is valued by customers for creating stable dispersions in complex crop formulations, ensuring consistent distribution of actives and preventing formulation breakdown.

• Symiro™ biostimulant

  As the challenge to feed our growing global population continues, increasing crop growth and yields is becoming an important area of focus to meet the rising demand for food.

• Croda acquired crop enhancement company Plant Impact

  Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Croda acquires marine biotechnology specialists Nautilus

  World class scientists, focusing on using marine microbial biodiversity to discover novel actives and materials for applications across all Croda market sectors.

• Croda acquires Inventiva, encapsulation and delivery system technology

  It will form the basis of a research and technology platform for the encapsulation and delivery of Croda’s products, providing a new dimension in the company’s innovation programme.

• Croda acquires research enterprise Enza Biotech

  Developing the next generation of renewable surfactants using carbohydrate-based chemistry.

• Croda expands Iberchems fragrances offering with the acquisition of Parfex

  Croda has acquired a controlling majority 95.6% of Parfex’s outstanding shares, comprising the founding shareholders and certain minority investors.